Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v9i1: pp. 20-30 Eric E Lewis; Jeffrey W Lippitt Misc-Not classified 1999
No products in the cart.